Marksans Pharma Limited — Updates, 20-03-2025: Press Release

Marksans Pharma Limited’s manufacturing facility in Verna, Goa, has received approval from the Australian TGA to produce solid dosage forms, including tablets and hard capsules, for the Australian market. This strategic development allows Marksans to expand its offerings in Australia, with products to be marketed and distributed through its subsidiary, Nova Pharmaceuticals Australasia Pty Ltd. This move signifies a positive outlook for the company, enhancing its global footprint and potentially boosting revenue streams in a strategically important market. Investors should watch closely for how this expansion impacts financial performance and market presence.